▲ Peaking
Business
MeiraGTx scores $400M from Oberland Capital to help get 2 gene therapies to commercialization
MeiraGTx has secured up to $425 million in new funding pathways to advance two gene therapies toward commercialization.
1 trends tracked about this subject — the full history, oldest to newest below.
MeiraGTx has secured up to $425 million in new funding pathways to advance two gene therapies toward commercialization.